...
search icon
cogt-img

Cogent Biosciences Inc, Common Stock

COGT

NSQ

$7.49

-$0.08

(-1.06%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$821.84M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
586.72K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.02
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.28 L
$12.61 H
$7.49

About Cogent Biosciences Inc, Common Stock

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCOGTSectorS&P500
1-Week Return-6.08%1.76%-2.37%
1-Month Return-7.12%0.33%-3.79%
3-Month Return-33.07%-8.58%-0.46%
6-Month Return-18.16%-4.26%3.58%
1-Year Return60.38%1.27%22.47%
3-Year Return-5.37%5.33%25.17%
5-Year Return117.8%38.09%77.46%
10-Year Return-82.97%102.29%188.42%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue22.50M7.87M---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":34.98,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue43.71K25.74K147.00K5.88M3.59M[{"date":"2019-12-31","value":0.74,"profit":true},{"date":"2020-12-31","value":0.44,"profit":true},{"date":"2021-12-31","value":2.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":61.04,"profit":true}]
Gross Profit22.50M7.85M(147.00K)(5.88M)(3.59M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":34.87,"profit":true},{"date":"2021-12-31","value":-0.65,"profit":false},{"date":"2022-12-31","value":-26.13,"profit":false},{"date":"2023-12-31","value":-15.95,"profit":false}]
Gross Margin100.00%99.67%---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.67,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses54.68M90.07M75.55M147.84M208.13M[{"date":"2019-12-31","value":26.27,"profit":true},{"date":"2020-12-31","value":43.28,"profit":true},{"date":"2021-12-31","value":36.3,"profit":true},{"date":"2022-12-31","value":71.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(32.18M)(82.20M)(75.55M)(147.84M)(208.13M)[{"date":"2019-12-31","value":-3217800000,"profit":false},{"date":"2020-12-31","value":-8219900000,"profit":false},{"date":"2021-12-31","value":-7555100000,"profit":false},{"date":"2022-12-31","value":-14783900000,"profit":false},{"date":"2023-12-31","value":-20813000000,"profit":false}]
Total Non-Operating Income/Expense612.00K7.54M3.75M11.59M27.04M[{"date":"2019-12-31","value":2.26,"profit":true},{"date":"2020-12-31","value":27.87,"profit":true},{"date":"2021-12-31","value":13.85,"profit":true},{"date":"2022-12-31","value":42.86,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(31.83M)(74.81M)(72.27M)(140.24M)(192.41M)[{"date":"2019-12-31","value":-3183300000,"profit":false},{"date":"2020-12-31","value":-7480800000,"profit":false},{"date":"2021-12-31","value":-7227300000,"profit":false},{"date":"2022-12-31","value":-14024100000,"profit":false},{"date":"2023-12-31","value":-19241000000,"profit":false}]
Income Taxes(1.56M)(8.36M)(467.00K)(7.60M)-[{"date":"2019-12-31","value":-156000000,"profit":false},{"date":"2020-12-31","value":-835700000,"profit":false},{"date":"2021-12-31","value":-46700000,"profit":false},{"date":"2022-12-31","value":-759800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(30.27M)(66.45M)(71.81M)(132.64M)-[{"date":"2019-12-31","value":-3027300000,"profit":false},{"date":"2020-12-31","value":-6645100000,"profit":false},{"date":"2021-12-31","value":-7180600000,"profit":false},{"date":"2022-12-31","value":-13264300000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(31.83M)(74.81M)(72.27M)(140.24M)(177.66M)[{"date":"2019-12-31","value":-3183300000,"profit":false},{"date":"2020-12-31","value":-7480800000,"profit":false},{"date":"2021-12-31","value":-7227300000,"profit":false},{"date":"2022-12-31","value":-14024100000,"profit":false},{"date":"2023-12-31","value":-17766300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(30.27M)(66.45M)(71.81M)(132.64M)(192.41M)[{"date":"2019-12-31","value":-3027300000,"profit":false},{"date":"2020-12-31","value":-6645100000,"profit":false},{"date":"2021-12-31","value":-7180600000,"profit":false},{"date":"2022-12-31","value":-13264300000,"profit":false},{"date":"2023-12-31","value":-19241000000,"profit":false}]
EPS (Diluted)(4.20)(8.10)(1.85)(2.45)(2.40)[{"date":"2019-12-31","value":-420,"profit":false},{"date":"2020-12-31","value":-810,"profit":false},{"date":"2021-12-31","value":-185,"profit":false},{"date":"2022-12-31","value":-245,"profit":false},{"date":"2023-12-31","value":-240,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

COGT
Cash Ratio 6.32
Current Ratio 6.44

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

COGT
ROA (LTM) -44.02%
ROE (LTM) -78.47%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

COGT
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

COGT
Trailing PE NM
Forward PE NM
P/S (TTM) 1320.63
P/B 4.24
Price/FCF NM
EV/R 925.41
EV/Ebitda NM

FAQs

What is Cogent Biosciences Inc share price today?

Cogent Biosciences Inc (COGT) share price today is $7.49

Can Indians buy Cogent Biosciences Inc shares?

Yes, Indians can buy shares of Cogent Biosciences Inc (COGT) on Vested. To buy Cogent Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in COGT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cogent Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Cogent Biosciences Inc (COGT) via the Vested app. You can start investing in Cogent Biosciences Inc (COGT) with a minimum investment of $1.

How to invest in Cogent Biosciences Inc shares from India?

You can invest in shares of Cogent Biosciences Inc (COGT) via Vested in three simple steps:

  • Click on Sign Up or Invest in COGT stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cogent Biosciences Inc shares
What is Cogent Biosciences Inc 52-week high and low stock price?

The 52-week high price of Cogent Biosciences Inc (COGT) is $12.61. The 52-week low price of Cogent Biosciences Inc (COGT) is $4.28.

What is Cogent Biosciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cogent Biosciences Inc (COGT) is

What is Cogent Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cogent Biosciences Inc (COGT) is 4.24

What is Cogent Biosciences Inc dividend yield?

The dividend yield of Cogent Biosciences Inc (COGT) is 0.00%

What is the Market Cap of Cogent Biosciences Inc?

The market capitalization of Cogent Biosciences Inc (COGT) is $821.84M

What is Cogent Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Cogent Biosciences Inc is COGT

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top